FDA Clearance Tracker · P050053-S005
INFUSE BONE GRAFT
Last checked: Nov 20, 2026Latest source record: Aug 15, 2008 (this decision)Source: openFDAMethods & limitations
Decided
Aug 15, 2008
Approved
Time to decision
283 days
Received Nov 6, 2007. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P050053-S005
- Device name
- INFUSE BONE GRAFT
- Applicant
- Medtronic, Inc.
- Applicant location
- Memphis, TN
- Received
- Nov 6, 2007
- Decided
- Aug 15, 2008
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P050053
Device type
- Device class
- Class III
- Regulation
- 21 CFR 872.3930
- Specialty
- Dentistry & Oral Surgery
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A MANUFACTURING SITE LOCATED AT INTEGRA NEUROSCIENCES PR, INC., ANASCO, PUERTO RICO, AND A STERILIZING SITE AT STERITECH, INC., SALINAS, PUERTO RICO.
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.